Meeting of the Advisory Committee on Infant and Maternal Mortality

AGENCY:

Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS).

ACTION:

Notice.

SUMMARY:

In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant and Maternal Mortality (ACIMM or Committee) has scheduled a public meeting. Information about ACIMM and the agenda for this meeting can be found on the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES:

• October 16, 2024, from 9:30 a.m. to 5:15 p.m. Eastern Time; and
• October 17, 2024, from 9 a.m. to 1 p.m. Eastern Time.

ADDRESSES:

This meeting will be held in person at the Hubert H. Humphrey Building, HHS Headquarters, 200 Independence Avenue SW, Conference Room 505A, Washington, DC 20201, and virtually via webinar. The webinar link and log-in information will be available at the ACIMM website before the meeting at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

SUPPLEMENTARY INFORMATION:

ACIMM is authorized by section 222 of the Public Health Service Act (42 U.S.C. 217a), as amended. The Committee is governed by provisions of the Federal Advisory Committee Act (5 U.S.C. chapter 10), as amended.

ACIMM advises the Secretary of HHS on department activities, partnerships, policies, and programs directed at reducing infant mortality, maternal mortality and severe maternal morbidity, and improving the health status of infants and women before, during, and after pregnancy. The Committee provides advice on how to coordinate federal, state, local, tribal, and territorial governmental efforts designed to improve infant mortality, related adverse birth outcomes, and maternal health, as well as influence similar efforts in the private and voluntary sectors. The Committee provides guidance and recommendations on the policies, programs, and resources required to address the disparities and inequities in infant mortality, related adverse birth outcomes and maternal health outcomes, including maternal mortality and severe maternal morbidity. With its focus on underlying causes of the disparities and inequities seen in birth outcomes for women and infants, the Committee advises the Secretary of HHS on the health, social, economic, and environmental factors contributing to the inequities and proposes structural, policy, and/or systems level changes.

The agenda for the October 16-17, 2024, meeting is being finalized and may include the following topics: federal updates; presentations and Committee discussions on the workgroup topics of rural health care access, social drivers of health, and women's health before/between pregnancies; and discussion of possible recommendations to achieve optimal maternal health and overall birth outcomes for underserved populations, including Black/African American families. Agenda items are subject to change as priorities dictate. Refer to the ACIMM website listed above for any updated information concerning the meeting.

Members of the public will have the opportunity to provide written or oral comments. Public participants may submit written statements in advance of the scheduled meeting by emailing SACIM@hrsa.gov. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACIMM should be sent to Vanessa Lee, Designated Federal Official, using the email address above at least 3 business days prior to the meeting.

Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Vanessa Lee at the contact information listed above at least 10 business days prior to the meeting. Since this meeting occurs in a federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 20 business days prior to the meeting to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry.

[FR Doc. 2024-19741 Filed 9-3-24; 8:45 am]

BILLING CODE 4165-15-P